Literature DB >> 20083704

Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.

Alexis Guyot, Nicolas Ortonne, Laurence Valeyrie-Allanore, Martine Bagot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083704     DOI: 10.1001/archdermatol.2009.345

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  7 in total

1.  [Systemic treatment of cutaneous lymphomas].

Authors:  C-D Klemke
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

2.  [Management of cutaneous lymphomas].

Authors:  J P Nicolay; C-D Klemke
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

3.  Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief review of literature.

Authors:  A Patsatsi; A Kyriakou; V Karavasilis; K Panteliadou; D Sotiriadis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

Review 4.  Cutaneous primary B-cell lymphomas: from diagnosis to treatment.

Authors:  Margarida Lima
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

5.  Primary cutaneous B-cell lymphoma-leg type in a young adult with HIV: a case report.

Authors:  Pamela Contreras-Chavez; Alejandro Sanchez-Nadales; Igor Babets; Romesa Sajjad-Hassan; Frederick Lansigan
Journal:  Oxf Med Case Reports       Date:  2020-11-24

Review 6.  Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.

Authors:  Jinjing Jia; Wensheng Li; Yan Zheng
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

Review 7.  MicroRNAs in Cancer Treatment-Induced Cardiotoxicity.

Authors:  Laura Pellegrini; Sara Sileno; Marco D'Agostino; Eleonora Foglio; Maria Cristina Florio; Vincenzo Guzzanti; Matteo Antonio Russo; Federica Limana; Alessandra Magenta
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.